GRIN2A and early-onset autosomal dominant Alzheimer disease: Most of the drugs corresponding to GRIN2A are antidepressants as well as antipsychotics, such as apimostinel, esketamine, and haloperidol, which improve cognitive deficits caused by the early stages of Alzheimer’s disease (66, 67).